Apparatuses and methods for negative pressure wound therapy

Information

  • Patent Grant
  • 11247034
  • Patent Number
    11,247,034
  • Date Filed
    Thursday, April 12, 2018
    6 years ago
  • Date Issued
    Tuesday, February 15, 2022
    2 years ago
Abstract
Disclosed herein are several embodiments of a reduced pressure appliance and methods of using the same in the treatment of wounds. Some embodiments are directed to improved fluidic connectors or suction adapters for connecting to a wound site, for example using softer, kink-free conformable suction adapters. Certain embodiments are directed to connectors used to connect fluid passage tube used in transmitting negative pressure to a fabric channel used in a suction adapter.
Description
FIELD OF THE INVENTION

Embodiments of the present invention relate generally to the treatment of wounds using negative pressure wound therapy, and more specifically to an improved apparatus and method thereof.


BACKGROUND OF THE INVENTION

The treatment of open or chronic wounds that are too large to spontaneously close or otherwise fail to heal by means of applying negative pressure to the site of the wound is well known in the art. Negative pressure wound treatment systems currently known in the art commonly involve placing a cover that is impermeable to liquids over the wound, using various means to seal the cover to the tissue of the patient surrounding the wound, and connecting a source of negative pressure (such as a vacuum pump) to the cover in a manner so that an area of negative pressure is created under the cover in the area of the wound.


SUMMARY OF THE INVENTION

Embodiments of the invention disclosed herein are directed to a reduced pressure appliance and methods of treatment using a reduced pressure appliance, and may be useful in the treatment of wounds using reduced pressure.


Certain embodiments of the invention employ fluidic connectors and/or suction adapters for connecting a source of negative pressure to a dressing positioned over a wound site. These fluidic connectors and/or suction adapters offer advantages over the prior art. For example and for illustrative purposes only, some of the embodiments may offer a softer, kink-free fluidic connector for connecting a wound site to a source of negative pressure for treatment. Such a fluidic connector and/or suction adapter is faster to apply, requiring fewer steps compared to prior art connectors, and offers greater patient comfort and safety by being soft and conformable, thereby avoiding pressure ulcers and other complications caused by harder connectors.


Also disclosed herein are embodiments of an apparatus for providing suction to a wound site comprising a top and bottom layer constructed from a liquid-impermeable material with a 3D knitted or 3D fabric material located between these top and bottom layers and forming an elongate channel.


In another embodiment of a suction adapter, this adapter has an applicator with an upper and lower surface, with the upper surface connected to the distal end of a bridge. The bridge has a proximal end and a distal end, and has an upper fluid passage connected to an air leak and a lower fluid passage in fluid communication with a source of negative pressure, with the lower fluid passage comprising a 3D knitted or 3D fabric material.


In some embodiments of the suction adapter, the upper fluid passage may comprise foam. The bridge portion may further comprise a top layer, a bottom layer and an intermediate layer, each of the layers having proximal ends and distal ends and elongate portions extending therebetween, where the upper fluid passage extends between the top and intermediate layers, and the lower fluid passage extends between the intermediate and bottom layers. The distal end of the bridge may also have an enlarged shape. The air leak may be disposed at the proximal end of the bridge. The 3D knitted or 3D fabric material may include a top knitted layer, a bottom knitted layer, and a middle area with vertically extending fibers, and may be approximately 1.5 to 6 mm thick. The 3D knitted or 3D fabric material may be constructed so as to resist compression to less than half its original thickness when subjected to a load of 15 psi.


The suction adapter embodiments above may be used in embodiments of a negative pressure wound treatment system comprising a flexible drape configured to be positioned over a wound and sealed to the skin surrounding the wound, and where the suction adapter is configured to be attached to the drape so as to surround at least one aperture formed in the drape. A vacuum pump is preferably connected by at least one conduit to the suction adapter.


Methods of treating a wound with negative pressure are also disclosed herein. A method of treating a wound site with negative pressure comprises applying a flexible drape over a wound site, applying a flexible suction adapter over an opening in the flexible drape, where the flexible suction adapter comprises top and bottom layers constructed from a liquid-impermeable material, a 3D knitted or 3D fabric material located between the top and bottom layers, an aperture in the bottom layer in fluid communication with the wound site through the opening and the 3D knitted or 3D fabric material, and applying negative pressure to the wound, the negative pressure being transmitted to the wound through at least one conduit connected between the source of negative pressure and the flexible suction adapter and passing through the 3D knitted or 3D fabric material through the aperture in the bottom layer and into the opening in the flexible drape.


In some embodiments, the application of negative pressure to the wound may cause air to flow into the wound via an air leak disposed on the flexible suction adapter. The flow rate of air, may, in some embodiments be at least 0.08 liters/minute when negative pressure is applied to the suction adapter, and this flow rate may be maintained while a weight is placed on the suction adapter, for example a 4.75 kg weight. Adhesive may be placed on the suction adapter when adhering the adapter to the drape, or the adapter can be supplied pre-attached to a drape. Otherwise, the method above may comprise cutting an opening into the drape. Wound contact material can also be placed into the wound site prior to applying the drape. A similar method may transmit negative pressure to the wound through at least one conduit connected between the source of negative pressure and the flexible suction adapter and that passes through the 3D knitted material into the opening in the flexible drape.


In another embodiment, a negative pressure wound treatment system comprises a conduit, a suction adapter and a connector. The conduit is configured to deliver negative pressure to the wound from a source of negative pressure. The suction adapter is configured to deliver negative pressure to the wound, wherein the suction adapter comprises an elongate fluid channel having a proximal and a distal end and an elongate 3D knitted or 3D fabric material extending between the proximal and distal ends. A connector is configured to securely attach to a proximal portion of the 3D knitted or 3D fabric material, the connector being further configured to create a fluidic connection between the 3D knitted material in the elongate fluid channel and the conduit. In certain embodiments, the connector is configured to remain attached to the 3D knitted or 3D fabric material when subjected to a pulling force of less than 20 kg.


In some embodiments, the connector comprises two distally extending projections, each projection further comprising at least one barb located thereon, the barbs configured to be pushed into and be retained within a proximal portion of the 3D knitted or 3D fabric material. The connector may further comprise two distally extending projections, each projection further comprising at least one barb located thereon, the barbs configured to attach to upper and lower portions of the 3D knitted or 3D fabric material.


In other embodiments, the connector comprises a central distally extending projection configured to extend into the 3D knitted or 3D fabric material. The central projection may further comprise at least one barb.


In another embodiment, the connector comprises at least one opening configured to receive a pin or other locking device, and wherein the pin is pushed through at least a portion of the 3D knitted or 3D fabric material.


In another embodiment, the connector comprises a central channel and at least one lip configured to be pushed into and secured inside a proximal portion of the 3D knitted or 3D fabric material.


In another embodiment, the connector comprises at least one flexible line and one corresponding cavity configured to receive the at least one line, the line being configured to loop into a proximal portion of the 3D knitted or 3D fabric material. The line may further comprise at least one barb.


In another embodiment, a connector for connecting a fluid passage tube to a fabric channel is provided. The connector comprises a hollow cylindrical body comprising a central channel extending between a proximal end and a distal end of the hollow body. A plurality of projections extend distally from the hollow body. A plurality of barbs are provided on each of the projections, wherein the barbs are angled proximally, the barbs being configured to engage the fabric channel. A frustoconical lip at the proximal end of the hollow body is configured to be press-fit into the fluid passage tube. The connector is configured to withstand a pulling force of up to 20 kg before disengaging from the fabric channel.


In another embodiment, the connector for connecting a fluid passage tube to a fabric channel comprises a body having a proximal end and a distal end. At least one member extends distally from the body, the at least one member configured to extend into the fabric channel. The proximal end of the body is configured to be press-fit with an inner or outer surface of the fluid passage tube.


In some embodiments, the body may be cylindrical and/or hollow. The at least one member may comprise a plurality of projections, and the projections may additionally comprise one or more barbs extending in a proximal direction. The member may alternatively comprise at least one flexible line, and wherein the line comprises a tapered tip configured to loop through the fabric channel and be received and securely connected to a cavity formed in the connector. The proximal end of the body may comprise a frustoconical lip.


In another embodiment, a fluidic connection is provided, comprising any of the aforementioned connectors. A fabric channel is engaged with the proximal end of the connector. A tube is engaged with the distal end of the connector.


In another embodiment, a method of transporting fluid. The method comprises providing an elongate fluid channel comprising a 3D knitted or 3D fabric material. A connector is attached to the 3D knitted or 3D fabric material, wherein a distal end of the connector engages the 3D knitted or 3D fabric material. A conduit is attached to a proximal end of the connector. Fluid is transported through the 3D knitted or 3D fabric material, through the connector and through the conduit.


In some embodiments, the transporting of fluid comprises applying negative pressure to the conduit, the connector and the 3D knitted or 3D fabric material. The 3D knitted or 3D fabric material may be placed in fluid communication with a wound, wherein applying negative pressure comprises transmitting negative pressure through the conduit, the connector and the 3D knitted or 3D fabric material to the wound. In one embodiment, pulling on the connector with a force less than 20 kg does not dislodge the connector from the 3D knitted or 3D fabric material.





BRIEF DESCRIPTION OF THE DRAWINGS


FIG. 1 illustrates a negative-pressure system that can be used in the treatment of wounds.



FIG. 2A illustrates an embodiment of a negative pressure wound treatment system comprising a pump, and illustrating a flexible suction adapter being applied to a wound.



FIG. 2B illustrates the embodiment of FIG. 2A, with the flexible suction adapter having been placed over a wound.



FIG. 2C illustrates an isometric view of a flexible suction adapter that may be used in a negative pressure wound treatment system.



FIG. 2D illustrates an exploded view of the flexible suction adapter of FIG. 2C.



FIG. 2E illustrates a close-up view of the proximal end of the flexible suction adapter of FIG. 2D.



FIG. 2F illustrates a close-up cutaway view of the proximal end of the flexible suction adapter of FIG. 2C.



FIG. 2G illustrates a top view of the flexible suction adapter of FIG. 2C.



FIG. 2H illustrates a side view of the flexible suction adapter of FIG. 2C.



FIG. 2I illustrates a bottom view of the flexible suction adapter of FIG. 2C.



FIG. 2J illustrates an exploded view of an alternative flexible suction adapter.



FIG. 3A illustrates a top view of a 3D fabric that may be used in a negative pressure wound treatment system.



FIG. 3B illustrates a bottom view of the 3D fabric of FIG. 3A.



FIG. 3C illustrates a side cutaway view of the 3D fabric of FIG. 3A.



FIGS. 4A-B illustrate an embodiment of a connector with two or more projections and that may be connected to a suction adapter illustrated in FIG. 2.



FIGS. 4C-D illustrate an embodiment of a connector with a distally-extending barb.



FIG. 4E illustrates an embodiment of a connector with a central rod.



FIG. 4F illustrates an embodiment of a connector with a securing pin.



FIG. 4G illustrates a similar embodiment to FIG. 4F provided with a projection.



FIG. 4H illustrates an embodiment of a connector provided with hooked barbs.



FIG. 4I illustrates an embodiment of a connector provided with a barb disposed around a central channel.



FIGS. 4J-L illustrate an embodiment of a connector comprising one or more connectors configured to be received into a corresponding cavity.



FIGS. 5A-G illustrate, respectively, front perspective, front, back, left side, right side, top and bottom views of an embodiment of a connector with two or more projections.



FIG. 5H illustrates a cross-section of the embodiment of FIGS. 5A-5G.



FIG. 5I illustrates a view of the connector of FIGS. 5A-5H being connected into a suction adapter as illustrated in FIG. 2A.





DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS

Preferred embodiments disclosed herein relate to wound therapy for a human or animal body. Therefore, any reference to a wound herein can refer to a wound on a human or animal body, and any reference to a body herein can refer to a human or animal body. The term “wound” as used herein, in addition to having its broad ordinary meaning, includes any body part of a patient that may be treated using reduced pressure. Wounds include, but are not limited to, open wounds, pressure sores, ulcers and burns. Treatment of such wounds can be performed using negative pressure wound therapy, wherein a reduced or negative pressure can be applied to the wound to facilitate and promote healing of the wound. It will also be appreciated that the negative pressure systems and methods as disclosed herein may be applied to other parts of the body, and are not necessarily limited to treatment of wounds.


With reference initially to FIG. 1, treatment of a wound with negative pressure in certain embodiments of the application uses a system as illustrated schematically. In one embodiment, a wound 101 may be partly or completely filled with a wound packing material 102, such as foam, gauze, or any other suitable material. Alternatively, no wound packing material may be utilized. A flexible drape 103 that is at least partially fluid impermeable, and preferably liquid impermeable, may then be laid over the wound packing material 102 and preferably onto at least part of the surrounding healthy skin surrounding a wound. The drape 103 may be connected via a conduit 104 such as a flexible tube to a source of negative pressure 106 such as a pump. This conduit 104 may, in some embodiments, comprise one or more tubes. Suitable sources for negative pressure include both powered negative pressure sources such as vacuum pumps, and manually powered negative pressure sources such as suction bulbs. Negative pressure is applied to the wound through the conduit 104 and through the wound packing material 102, and wound exudate and other secretions are drawn away from the wound, through the wound packing material, and into a canister or other collection unit 105. The collection unit 105 may be located along the conduit before the negative pressure source, or may be located elsewhere relative to the negative pressure source. In some embodiments, one or more filters 107 may be provided along the vacuum pathway, for example at the outlet of the pump. This filter 107 may be useful for absorbing odors or may be a bacterial filter. Suitable systems for treating wounds in the above manner include the RENASYS-F, RENASYS-G, RENASYS EZ and RENASYS GO systems available from Smith & Nephew.


The application of reduced or negative pressure to a wound in the above manner may be used to promote faster healing, increase blood flow, decrease bacterial burden, increase the rate of granulation tissue formation, remove exudate and slough from the wound, alleviate interstitial edema, stimulate the proliferation of fibroblasts, stimulate the proliferation of endothelial cells, close chronic open wounds, inhibit burn penetration, and enhance flap and graft attachment, among other things. It has also been reported that wounds that have exhibited positive response to treatment by the application of negative pressure include infected open wounds, decubitus ulcers, dehisced incisions, partial thickness burns, and various lesions to which flaps or grafts have been attached.


Suitable drapes such as those used in the embodiments described herein are preferably liquid tight, such that at least partial negative pressure may be maintained at the wound site. The drape may be constructed from, for example, transparent flexible plastics such as polyurethane. Other suitable materials include without limitation synthetic polymeric materials that do not absorb aqueous fluids, including polyolefins, such as polyethylene and polypropylene, polysiloxanes, polyamides, polyesters, and other copolymers and mixtures thereof. The materials used in the drape may be hydrophobic or hydrophilic. Examples of suitable materials include Transeal® available from DeRoyal and OpSite® available from Smith & Nephew. In order to aid patient comfort and avoid skin maceration, the drapes in certain embodiments are at least partly breathable, such that water vapor is able to pass through without remaining trapped under the dressing. Lastly, although several embodiments illustrated herein illustrate an operator cutting an aperture into a drape manually, drapes used in the embodiments disclosed here may also be provided with one or more pre-cut apertures.


The wound is optionally filled with a wound packing material. Preferably, this wound packing material is conformable to the wound bed. This material is preferably soft and resiliently flexible. Examples of suitable forms of such wound fillers are foams formed of a suitable material, e.g. a resilient thermoplastic. Preferred materials for the present wound dressing include reticulated polyurethane foams with small apertures or pores and open-celled foams. Other suitable materials may include gauze. Preferably, such wound packing material will be able to channel wound exudate and other fluids through itself when negative pressure is applied to the wound. Some wound packing materials may include preformed channels or openings for such purposes.


Typically, the negative pressure wound treatment system is operated until a wound has reached a level of healing acceptable to a physician. The treatment system is preferably operated using a negative or reduced pressure ranging from about 40 to 200 mm Hg, though the amount may be lower or higher depending on physician preference. The time period for use of the wound treatment apparatus on a wound is selected by the physician. During the time period that negative pressure is applied, dressing changes and other temporary interruptions to the treatment may occur. Preferably, the negative pressure wound treatment system is able to handle at least 1 L of wound exudate or other fluid per day, or 0.694 ml/min. Some embodiments may handle over 10 L of wound exudate per day.


In preparing a wound site for treatment with the embodiments described herein, the wound is typically cleaned, debrided, and dried in a medically-acceptable manner. Optionally, the wound site may be filled partly or completely with a wound packing material 102 as shown in FIG. 1, including for example but without limitation gauze or foam. This wound packing material may be trimmed to fit into the wound space. Next, a drape 103 is placed to cover the wound site while overlapping onto the healthy skin surrounding the wound; in some cases, the drape may need to be trimmed to size. Depending on the type of drape, a skin sealant may need to be applied to the skin surrounding the wound prior to placing the drape so that the drape may be adhered to the skin. Preferably, the drape 103 has an adhesive layer on its wound-facing side. Once adhered to the skin, the drape should form an air-tight seal against the skin. In order to treat the wound using negative pressure, some embodiments disclosed herein may require that the drape be pierced (for example to insert a conduit or to communicate with a suction adapter as described below) to create an aperture leading to the wound site. Obviously, some drapes may have an aperture or apertures already pre-cut or preformed into the drape, and some embodiments disclosed herein may not require an aperture to be made (as shown in FIG. 1). After application of negative pressure to the wound site, wound exudate and other fluids may be drawn away from the wound site and into a suitable receptacle 105, preferably interposed between the wound site and the source of negative pressure 106. Application of negative pressure is continued (with intervening dressing changes, if necessary) until the wound has reached a desired level of healing.



FIGS. 2A-J illustrate embodiments of a negative pressure wound treatment system 5501. Here, the system 5501 may comprise a bridge 5502 having a proximal end 5503 and a distal end 5505 and an applicator 5520 at the distal end 5505 of the bridge 5502 forming a flexible suction adapter. Preferably, the system 5501 comprises a bridge 5502. A connector 5504 is preferably disposed at the proximal end 5503 of the bridge 5502, so as to connect to at least one of the channels 5512 and/or 5516, as shown in FIG. 2D. A cap 5536 may be provided with the system 5501 (and can in some cases, as illustrated, be attached to the connector 5504). The cap 5536 can be useful in preventing fluids from leaking out of the proximal end 5503. In some embodiments, the connector 5504 may be an MQC Series™ quick connector, as sold by Value Plastics (Fort Collins, Colo.). The system 5501 may include a source of negative pressure such as a pump or negative pressure unit 5534 capable of supplying negative pressure. The pump also preferably comprises a canister or other container for the storage of wound exudates and other fluids that may be removed from the wound. In some embodiments, this pump 5534 can be a RENASYS GO pump, as sold by Smith & Nephew. The pump 5534 may be connected to the connector 5504 via a tube 5540. In use, the applicator 5520 is placed over an aperture 5535 formed in a drape 5531 that is placed over a suitably-prepared wound 5530, which may in some cases be filled with a wound packing material such as foam or gauze. Subsequently, with the pump 5534 connected via the tube 5540 to the connector 5504, the pump is activated, thereby supplying negative pressure to the wound. Application of negative pressure may be applied until a desired level of healing of the wound 5530 is achieved.


Here, and with particular reference to FIGS. 2C-D, the system 5501 may comprise a bridge 5502 having a proximal end 5503 and a distal end 5505 and an applicator 5520 at the distal end 5505 of the bridge 5502. In some embodiments, the bridge 5502 may comprise an upper channel layer 5512 positioned between an upper layer 5510 and an intermediate layer 5514, with a lower channel layer 5516 positioned between the intermediate layer 5514 and a bottom layer 5518. Preferably, the layers 5510, 5514, and 5518 have elongate portions extending between proximal and distal ends and may be comprised of a material that is fluid-impermeable, for example polymers such as polyurethane. It will of course be appreciated that the layers 5510, 5514, and 5518 may each be constructed from different materials, including semi-permeable materials. As illustrated in FIG. 2D, the upper and lower layers 5510 and 5518 may be curved, rounded or outwardly convex over a majority of their lengths. During assembly, for example, the layers 5510, 5514, and 5518 may be pinched together to weld or adhere the layers together. In doing so, the proximal ends of the channels 5512 and 5516 may be sandwiched between these layers, thus partially compressing the proximal ends of the channels 5512, 5516 and stretching the layers 5510, 5514, 5518 over these aforementioned proximal ends. Of course, the proximal ends of the materials used in the bridge section 5502 may not necessarily be rounded or curved; as shown in FIG. 2J, they can remain substantially squared off and straight.


The upper and lower channel layers 5512 and 5516 are preferably elongate layers extending from the proximal end 5503 to the distal end 5505 and may each preferably comprise a porous material, including for example open-celled foams such as polyethylene or polyurethane. In some embodiments, one or more of the upper and lower channel layers 5512 and 5516 may be comprised of a fabric, for example a knitted or woven spacer fabric (such as a knitted polyester 3D fabric, Baltex 7970®, or Gehring 879®) or a nonwoven material. Suitable materials may also include terry-woven or loop-pile materials. The fibers may not necessarily be woven, and can include felted and flocked (including materials such as Flotex®) fibrous materials. The materials selected are preferably suited to channeling wound exudate away from the wound and for transmitting negative pressure and/or vented air to the wound site, and may also confer a degree of kinking or occlusion resistance to the channel layers 5512 and 5516 as described below. In one embodiment, the upper channel layer 5512 may comprise an open-celled foam such as polyurethane, and the lower channel layer may comprise a fabric as described herein. In another embodiment, the upper channel layer is optional, and the system may instead be provided with an open upper channel. In the embodiment illustrated in FIG. 2D, the upper channel layer 5512 may have a curved, rounded or upwardly convex upper surface and a substantially flat lower surface, and the lower channel layer 5516 may have a curved, rounded or downwardly convex lower surface and a substantially flat upper surface.


In some embodiments, the fabric may have a three-dimensional structure, where one or more types of fibers form a structure where the fibers extend in all three dimensions. Such a fabric may in some cases aid in wicking, transporting fluid, and/or transmitting negative pressure. To prevent the channels 5512 and/or 5516 from being displaced or twisted while encased in the system 5501—which may impair performance of the respective channels under negative pressure—it may in some embodiments be preferable to adhere or otherwise secure the channels 5512 and/or 5516 to one or more of the layers 5510, 5514, and 5518. In certain embodiments, these materials remain open and capable of communicating negative pressure to a wound area under the typical pressures used in negative pressure therapy, for example between 40 to 150 mmHg, although higher and lower values are possible. In some embodiments, the fabric may comprise several layers of material stacked or layered over each other, which may in some cases be useful in preventing the channel 5516 from collapsing under the application of negative pressure. In other embodiments, the fabric used in channel 5516 may be between 1.5 mm and 6 mm; more preferably, the fabric may be between 3 mm and 6 mm thick, and may be comprised of either one or several individual layers of fabric. In other embodiments, the channel 5512 may be between 1.2-3 mm thick, and preferably thicker than 1.5 mm. Additionally, and as described previously, the materials used in the system 5501 are preferably conformable and soft, which may help to avoid pressure ulcers and other complications which may result from a wound treatment system being pressed against the skin of a patient. Further examples of 3D fabrics are discussed below in FIGS. 3A-C.


Preferably, the distal ends of the layers 5510, 5514, and 5518 and the channel layers 5512 and 5516 are enlarged at their distal ends (to be placed over a wound site), and may form a “teardrop” or other enlarged shape. The distal ends of at least the layers 5512, 5514, 5516, and 5518 may also be provided with at least one through aperture. This aperture may be useful not only for the drainage of wound exudate and for applying negative pressure to the wound, but also during manufacturing of the device, as these apertures may be used to align these respective layers appropriately.


With additional reference to FIGS. 2D-E and J, a channel connector 5506 is provided at the proximal end 5503 of the bridge 5502, the channel connector 5506 preferably being configured so as to be embedded into the lower channel layer 5516 so as to create a secure fluidic connection. The channel connector 5506 may in some embodiments be inserted into a pre-made cavity formed into the channel 5516; as illustrated in FIG. 2J, this cavity can be cut out or can be in the form of a rabbet joint. In some embodiments, the channel connector 5506 may be one of the connectors described in FIGS. 4A-L below. With one end of the channel connector 5506 being embedded into the lower channel layer 5516, the other end of the channel connector 5506 may be connected or in communication with, in one embodiment, a connector tube 5507, although in some embodiments the channel connector 5506 may be connected directly to the connector 5504, or else connected directly to a tube 5540 connected to a source of negative pressure. When using a connector tube 5507, the resulting assembly can permit a connector 5504 to be attached thereto. A cap 5536, which may be secured to the suction adapter for example via a cap leash 5527 secured with a ring disposed on the outer surface of the connector tube 5507. The cap 5536 may be used to cover the end of the suction adapter, for example at the connector 5504, so as to prevent exudate and other wound fluids from leaking out. The connector 5504 is preferably configured to connect with a tube 5540 connected to a source of negative pressure. The connector 5504 may for example comprise a lip or other such structure to aid in securing the connector 5504 to a tube 5540 and/or cap 5536, although it will be understood that other connector types are possible, including quick-disconnect couplings, luer locks, Christmas-tree, and other such connectors.


The upper layer 5510 may comprise additional material extending downward, preferably at least of the thickness of the bridge 5502; this material may then be used to bond or weld to the other layers so to form a fluid-tight seal. More specifically, during assembly, the upper layer 5510 may be attached, for example by melting, welding, or with adhesives, to the lower layer 5518 so as to form a fluid-tight seal (with the exception of the apertures at the distal and proximal ends). Preferably, the middle layer 5514 is attached to the top layer 5510 and the bottom layer 5518. In some embodiments, it may be preferable to attach or bond the connectors 5504 and/or 5506, as well as the tube 5507 to at least one of the layers 5510, 5514, 5518 so as to create a fluid-tight connection. To provide for a more secure connection, some embodiments may also be provided with a weld 5532 made onto the lower layer 5518. The lower channel 5516 may have a hole or aperture made through it, which may be used to weld it, via the weld 5532, to the lower layer 5518. This welding of the lower channel 5516 to the lower layer 5518 via the weld 5532 made through the hole 5533 may thus aid in preventing the various layers and channels from shifting or being displaced. Obviously, it will be understood that other securement means may be used, for example adhesives and the like, and that such arrangements may be also be used in the upper channel 5512.


In certain embodiments, for example as illustrated in FIGS. 2C-J, a controlled air leak 5524 may be disposed on the bridge portion 5502, for example at the proximal end thereof. This air leak 5524 may comprise an opening or channel extending through upper layer 5510, such that the air leak 5524 is in fluidic communication with the upper channel 5512. Upon the application of suction to the system 5501, air will enter through the air leak 5524 and move from the proximal end 5503 to the distal end 5505 along the upper channel 5512. The air will then be suctioned into the lower channel 5516 by passing through the apertures through the distal ends of the layers 5512, 5514, 5516 and 5518. The air leak 5524 preferably comprises a filter 5525. Preferably, the air leak 5524 is located at the proximal end of the bridge portion 5502 so as to minimize the likelihood of wound exudate or other fluids coming into contact and possibly occluding or interfering with the air leak 5524 or its filter 5525. In some embodiments, this filter 5525 is a microporous membrane capable of excluding microorganisms and bacteria, and which may be able to filter out particles larger than 45 μm. Preferably, the filter 5525 can exclude particles larger than 1.0 μm, and more preferably, particles larger than 0.2 μm. Advantageously, some embodiments may provide for a filter 5525 that is at least partially chemically-resistant, for example to water, common household liquids such as shampoos, and other surfactants. In some embodiments, reapplication of vacuum to the system 5501 and/or wiping of the exposed outer portion of the filter 5525 may be sufficient to clear any foreign substance occluding the filter 5525. The filter 5525 may be composed of a suitably-resistant polymer such as acrylic, polyethersulfone, or polytetrafluoroethylene, and may be oleophobic and/or hydrophobic. In some embodiments, the filter 5525 may also comprise a supporting backing layer, for example a nonwoven polyester support. Preferably, the air leak 5524 will supply a relatively constant air flow that does not appreciably increase as additional negative pressure is applied to the system 5501. In embodiments of the system 5501 where the air flow through the air leak 5524 increases as additional negative pressure is applied, preferably this increased air flow will be minimized and not increase in proportion to the negative pressure applied thereto.


The filter 5525 provided in the controlled air leak 5524 in certain embodiments may be useful in a system 5501 for use with more ambulatory and active patients. For example, a chemically-resistant filter may permit a patient to bathe or shower without damaging the filter's functionality when reconnected to a source of negative pressure. Any occlusion or fluid blocking the air leak 5524 could then be cleared by, for example, wiping off the filter 5525 or re-applying negative pressure to the system 5501. Such a system would also have the advantage that the system 5501 and any assorted wound dressing materials, if present, would not need to be removed and then re-applied should a patient need to be disconnected from the source of negative pressure, for example incidental to bathing. This would entail significant advantages in improving the cost-effectiveness and ease of use of the present treatment system.


The system 5501 is preferably constructed so as to provide a consistent fluid flow even if the system 5501 is kinked or weighted down. For example, in use on a patient, the bridge portion 5502 may become folded over itself, or else the patient may roll over, thus placing his or her weight over at least a portion of the system 5501. Typically, prior art dressings and fluidic connectors become blocked or ineffective in such situations and in some cases may contribute to complications such as pressure ulcers. Here, however, certain embodiments provide for improved blockage resistance if kinked or weighed down. Preferably, by employing channel layers 5512 and 5516 as described above, and more preferably by employing a foam channel layer 5512 and a fabric channel layer 5516, the system 5501 is able to maintain a flow rate through the air leak 5524 of at least 0.08 L/min, and preferably 0.12 L/min while negative pressure is applied through a source of negative pressure. Further embodiments also provide for the system 5501 to be able to handle fluid exudate drainage from the wound site through the lower channel 5516 of at least 10 L/day, or 6.9 ml/min. Certain embodiments provide for the system 5501 to maintain these flow rates with a weight, for example a 12 kg weight, pressing down on the bridge portion through a rod with a 1 in. diameter. In some embodiments, these flow rates are also maintained while the bridge portion 5502 is kinked over itself with the same weight, or for example with a 4.75 kg weight placed directly on the folded region. It is preferable that the system 5501 be able to withstand being folded or kinked over even during an extended period of time, for example over 40 hours, and not show any degradation in performance (e.g., flow rates) compared to its performance prior to being folded or kinked over. Preferably, embodiments of the system 5501 are also able to transmit and maintain a negative pressure at the wound that is close to the negative pressure level at the source of negative pressure. For example, an acceptable level of pressure maintained at the wound may be within ±25 mmHg of the negative pressure set at the source of negative pressure, with this pressure being preferably maintained at this level within 95% of the time that the system 5501 has negative pressure applied to it. Acceptable pressure levels may include pressure ranges between 40-120 mmHg, although levels of 200 mmHg have successfully been used.


With additional reference to FIGS. 2A-D, G-J, the system 5501 also comprises an applicator 5520 designed for placement over a wound site. Preferably, the applicator 5520 comprises a flexible layer 5550, for example polyethylene or polyurethane, with a layer of adhesive on its lower (wound-facing) side. Optionally, a protective release layer 5529 may be placed on the adhesive layer, which is removable before use. In some embodiments, a more rigid removable backing layer 5552 may be provided on the upper side of the applicator 5520 to facilitate handling of the applicator 5520 due to the flexibility of the layer 5550. The applicator 5520 preferably comprises an attachment point for the bridge 5502 at the distal end 5505, for example using a section of double-sided adhesive tape 5528. The double-sided adhesive tape 5528 may be protected by an additional protective release layer, which is removed prior to adhering the bridge 5502 to the applicator 5520. It will be understood that different attachment methods are also contemplated, for example heat sealing, welding, or suitable adhesives. Some embodiments may also permit the manufacture of the bridge 5502 and the applicator 5520 as a single unit that does not require separate attachment means. The applicator 5520 preferably comprises at least one aperture 5526 through itself and designed to be placed over a wound site, and which can serve to fluidically connect the wound site to the source of negative pressure and to the air leak while also serving as a conduit to draw out wound exudate from the wound site.


In use, and with reference to FIGS. 2A-B, the system 5501 may be used in a similar fashion to the other embodiments previously disclosed herein. A wound site 5530 is preferably cleaned and prepared in a suitable fashion, and a wound packing material, if necessary, placed into the wound site, followed by a drape 5531. An aperture 5535 through the drape to the wound site is then created, although some embodiments may have a pre-made aperture 5535. Subsequently, an operator may situate the applicator portion 5520 over the aperture 5535. After removing the backing layer 5529 (if present) from the adhesive layer on the underside of the applicator portion 5520, the applicator is sealed to the drape 5531, and the backing layer 5552 (if present) is also removed from the applicator portion 5520. A fluidic conduit such as a tube 5540 may then be connected to the connector 5504. The tube 5540 may also be connected to connector 5504 prior to applying the applicator to the wound site. The fluidic conduit is connected to a source of negative pressure 5534, preferably with a container suitable for containing wound exudate interposed therebetween. The application of negative pressure may then be effectuated to the wound site 5530 until the wound site progresses to a desired level of healing.


During use of the system 5501, wound exudate from the wound site 5530 is drawn by the negative pressure through the lower channel layer 5516. The air leak 5524 allows air to pass through the upper channel layer 5512 into the apertures through the distal ends of the layers 5512, 5514, 5516 and 5518. The negative pressure draws air passing through the upper channel layer into the lower channel layer 5516 back toward the source of negative pressure or pump. In some embodiments, the controlled air leak 5524 provides a constant flow of air through the system 5501, which then may be used to determine whether blockage or leakage is present. Causes of blockage can include, for example, situations where the lower channel 5516 becomes occluded with wound debris. Leakage causes can include, for example, improper sealing of the drape over the wound site, or physical damage to the system 5501 leading to excess air leaking into the system. The blockage or leakage may be determined, in certain embodiments, by measuring the speed of the pump while the pump works to maintain a constant negative pressure. Pump speed may also be measured indirectly by measuring the amount of voltage or signal sent to the pump.



FIGS. 3A-C illustrate views of a 3D fabric that may be used in various embodiments described herein, for example the bridge 5502 of the suction adapter illustrated in FIGS. 2A-J. Although other porous materials such as foam may be used in the embodiments described herein, for example in the upper and lower channels 5512 and/or 5516 illustrated in FIGS. 2A-C, the use of 3D fabrics may be advantageous in some circumstances. Certain 3D fabrics have been found to perform well in conveying negative pressure to and wound exudate from a fluidic suction adapter, even while under compression—for example when a patient's weight is placed directly upon the suction adapter, or when negative pressure is applied—and/or when the fluidic suction adapter is kinked or folded. Some 3D fabrics that have been found to perform acceptably include knitted polyester 3D fabric, Baltex 7970®, Gehring 879®, or Coolmax®. Of course, other fibers and fabric types may be used in part or in whole to make 3D fabrics, and include without limitation polyamides such as nylon, viscose, cotton, as well as other synthetic microfibers. 3D fabrics may also be constructed at least in part from fibers such as Nomex® and Kevlar®. Other types of fabrics and materials disclosed elsewhere herein may also be used.


In one embodiment, as illustrated in FIGS. 3A-C, the 3D fabric may comprise a bottom side 5603, a top side 5605, and an open middle area 5607. FIG. 3A illustrates the bottom (wound-facing) side 5603 of a 3D fabric, which may be woven so as to create oblong or ovoid openings 5611 extending lengthwise across the fabric. In one embodiment, the oblong or ovoid openings 5611 represent or provide an open area of between 10 and 45% (or about 10% to about 45%) of the surface area of the bottom layer, more preferably 10% to 30% (or about 10% to about 30%). Here, fibers are knitted (for example by warp knitting) so as to also include these larger openings or pores that permit bulk transport of wound fluids in addition to wound fluids carried along the fibers by capillary action of the fibers. Apertures that are optionally formed in the distal end of the 3D fabric (as illustrated in FIGS. 2D and J) may also aid in the bulk evacuation of wound debris and fluids.



FIG. 3B illustrates the top side 5605 of a 3D fabric that may be used as described herein. This top side 5605 in one embodiment does not have the larger ovoid apertures 5611 of the bottom side 5603, but may have openings 5613 defined by fibers extending lengthwise and generally transversely or at an angle across the width of the fabric. As illustrated, these openings are generally rhombus-shaped. In one embodiment, these openings 5613 may represent or provide an open area greater than that of the bottom layer, for example between 30% and 50% (or about 30% and about 50%). Of course, it will be understood that the fabric presented here is a non-limiting example, and different fabric configurations and orientations are possible, for example with the top side 5605 being placed downward so as to face the wound and with the bottom side 5603 facing upward.



FIG. 3C illustrates a cross-section of a 3D fabric (the bulb-like projections on the vertical fibers in the fabric are an artifact of the cutting process). The vertically extending fibers 5609 may be woven so as to extend through the middle open area 5607 while also being connected to the bottom and top layers 5603 and 5605. Preferably, the fibers 5609 present in the open middle layer 5607 will have sufficient stiffness so as to help prevent compression of the fabric. As illustrated in this figure, and without wishing to be bound by theory, 3D fabrics that have been found to perform well will often include a larger open area 5607 in the middle portion that may permit exudates and other fluids to be effectively transported away from a wound site while under the application of negative pressure, while more densely-woven outer layers 5603, 5605 may aid in providing additional tensile strength and capillary wicking action. For example, the middle layer may include an open volume of greater than 50% (or greater than about 50%). Obviously, the resulting fabric cannot be too thick or composed of fibers that are too stiff, as the resulting suction adapter and system may not remain sufficiently flexible for comfortable usage with a patient.


It will often be advantageous to tailor the performance characteristics of the 3D fabric while in use to account for various requirements of the suction adapter. In particular, the flow rate of exudate through the fabric, for example when under compression, may be simplified by considering the porosity of the fabric. In such situations, and again without wishing to be bound by theory, the porosity of the fabric, and thus the space that will be available for fluids to travel through, may be determined in part by the knit pattern of the fibers used in creating the 3D fabric, the thickness of the fibers used therein, and their respective stiffness and hardness (especially when under compression). Fibers may also be modified by surface properties (the fibers can be flat or textured) and the number of fibers or filaments used in the resulting fabric. Compression resistance may be affected by the choice of fiber or monofilament used in the vertical axis of the fabric, and generally, a stiffer material will improve compression resistance on this axis. Other materials properties, such as hydrophobicity, may play a role. In some cases, it may be beneficial to treat the fabric to be hydrophilic, for example with a hydrophilic polymer, so as to improve wicking of fluids. Preferred embodiments of the 3D fabric used with certain suction adapters have been found to work well when Baltex® fabric is treated in such a fashion. Other possible treatments may include lipophilic coatings to prevent proteins from adhering and building up during use, which may cause clogging and loss of pressure to the wound site.


The flow rate through the 3D fabric while under the application of negative pressure may be approximated by considering each opening as a separate orifice plate subject to Bernoulli's principle while under laminar flow. To simplify calculations, the area of openings for a given area of 3D fabric may be used. Thus, the 3D fabric may be optimized to achieve a good balance between factors such as the compression resistance required and the resulting flow rate under the application of negative pressure. Further optimization will also take place with the stiffness and flow rate of the 3D fabric being tailored to application in the embodiments described herein. Optimization of the properties and dimensions of the 3D fabric will also preferably take into account a balancing between the flow rate and stiffness required and the conformability of the fabric, as a fabric that is too stiff may not bend appropriately and may also be uncomfortable on the patient. The 3D fabric should preferably be designed so as to yield when compressed against tissue, thereby preventing tissue compression (for example against bony prominences in the patient) and the discomfort and damage, such as pressure ulcers, that may follow. For example, the dimensions of the fabric may be tailored for the ultimate use of the suction adapter—smaller in the case of distal extremities such as fingers, and larger for abdominal and burn wounds. A fabric that is too stiff may also cause pressure ulcers and other such complications, although it may function acceptably in larger dimensions.


In practice, and as also described previously herein, flow rates through embodiments of the suction adapter using 3D fabrics are at least 0.08 L/min, preferably up to 10 L/min during the application of negative pressure, and should be able to handle fluid exudate drainage of at least 10 L/day. Some embodiments of the suction adapter may be configured to handle much larger wounds, including abdominal wounds, and which in some cases may exude at least 0.5 L/hr, or 12 L/day. In more extreme cases, the pump used (for example, the RENASYS EZ) may be able to evacuate up to 16 L/min, thereby evacuating a large wound to a negative pressure level of 120 mmHg in less than a minute. The pressure drop calculated due to the 3D fabric should be minimal, and the level of negative pressure measured at a wound site is preferably within 25 mmHg of the pressure level measured at the source of negative pressure. Although the pressure drop increases as the negative pressure applied increases (thus rendering the 25 mmHg target more difficult to reach), embodiments of the wound treatment system are preferably able to maintain this target pressure to at least a negative pressure of 200 mmHg. The suction adapter and system are preferably able to function within pressure ranges required for negative pressure, which are estimated to be from around 40 mmHg to 200 mmHg. Pressure ranges greater than 200 mmHg are possible, but these may in some circumstances cause patient discomfort. The apparatus may also function at lower pressure ranges, such as 20 mmHg, although at such low pressure levels the therapeutic effects resulting from negative pressure may be diminished, with the device acting more as a drainage device. Preferably, embodiments of a negative pressure treatment system are able to maintain these target pressures at the wound site within 95% of the time that negative pressure is being applied to the wound. In some embodiments, the fabric may comprise several layers of material stacked or layered over each other, which may in some cases be useful in preventing the channel 5516 from collapsing under the application of negative pressure. In other embodiments, the fabric used in channel 5516 may be between 1.5 mm and 6 mm; more preferably, the fabric may be between 3 mm and 6 mm thick, and may be comprised of either one or several individual layers of fabric. In other embodiments, the channel 5512 may be between 1.2-3 mm thick, and preferably thicker than 1.5 mm. Preferably, the 3D fabric is able to withstand a load of at least 5.3 psi with a compression of not more than 10% of the fabric's original thickness. Further, the 3D fabric may also be able to resist compression to less than half of its original thickness when subjected to a load of 15 psi.


In a preferred embodiment, a 3D fabric may be woven from 100% polyester using yarns of 150 and 225 Denier, to yield a fabric weighing approximately 23 to 25 oz per square yard. In these cases, the fabric may be approximately 5.8-6.8 mm thick. The bottom portion of the fabric may also have several openings or pores 5611 similar to those illustrated in FIG. 3A, which may be elongated, rectangular or ovoid in shape and oriented with their long axis lengthwise along the fabric. The openings 5611 may be arranged in a plurality of rows extending lengthwise across the fabric, for example 2 to 5 rows, or more preferably 3 rows as illustrated in FIG. 3A. The openings 5611 may be spaced equidistantly from each other in each of the rows, and may form a staggered pattern from one row to another. In one embodiment, each row may have approximately 6-10 openings, more preferably 8 openings, per 2 inches (or about 50 mm). Along a given width or transverse dimension of the fabric, the transverse rows formed by the openings may have a spacing of approximately 6-10 openings, more preferably 8 openings, per 2⅛ inches (or about 54 mm). In one embodiment, the openings may have a length of between about 1/16″ to about 1″ lengthwise, and a width of between about 1/32″ and ½″ widthwise. In one example, the openings measure approximately ⅛″ (or about 3.2 mm) lengthwise and 1/32″ (or about 0.79 mm) across. The 3D fabric in one embodiment may have an overall length of between about 50 and 100 mm, more preferably about 60 mm, a width between about 5 and 15 mm, more preferably about 9 mm, and a thickness of about 6 mm.


Embodiments of the systems described herein have been tested and found to perform satisfactorily. Such testing was performed by constructing suction adapters from embodiments described herein. The distal ends of the suction adapters were then placed over an aperture made onto a drape placed over a simulated wound cavity provided with a source of simulated wound fluid, which was controllable and which can vary the flow rate of the wound fluid. The simulated wound cavity was also in some cases packed with foam or some other wound packing material. In some tests, the simulated wound fluid was a 5:1 water to glycerol mix, and in others filtered horse serum (available from Oxoid, United Kingdom) was used. The proximal end of the suction adapter was then connected to a source of negative pressure, in this case a pump. Flow rate tests and other measurements were then conducted at various negative pressure ranges and simulated exudate flow rates and air leak rates.



FIGS. 4A-L illustrate embodiments of a connector 5704, similar to the connectors 1504 and 5506 described previously, and which may be used to securely connect a source of negative pressure to a channel 5716 of a suction adapter such as the ones described herein. For example, this channel 5716 may be the channels 5512 and 5516 in FIGS. 2-3. Generally, such connectors 5704 may be useful in providing a more secure connection from the source of negative pressure to a negative pressure treatment system. The use of these connectors 5704 is optional, and may not be necessary in all embodiments described herein. In use, a tube 5740 connected to the connector 5704 may pull, or other external forces may somehow disengage the connector 5704 away from the channel 5716 to which it is attached. In such situations, application of negative pressure to the wound may be reduced or stopped. Further means to secure the connector 5704 to the remainder of the system may, as described above, include bonding or attaching other layers of the treatment system, if present, to the connector 5704. For example, this may include bonding at least one of the layers 1510, 1514, 1518 to the connector 5704. The connectors 5704 may be designed so as to create a secure connection with a fabric or material used in a channel; when 3D fabrics or 3D knitted materials are used, some embodiments of the connector 5704 are configured to engage with or attach to a portion of the material or fibers of the material to create a more secure connection. Preferably, embodiments of the connector 5704 are able to withstand a pulling force of up to 20 kg before disconnection and/or failure of the connector occurs, preferably such that the connector disengages from the channel it is connected to. It will be understood that other embodiments may be configured to withstand a lower pulling force, and may be tailored to release so to prevent injury to a patient (for example, constriction of the suction adapter and/or drainage tubes around a limb).



FIGS. 4A-B illustrate an embodiment of the connector 5704a comprising two or more projections 5752 extending distally lengthwise from the preferably cylindrical main body of the connector 5704a. The main body also comprises a central channel 5755 extending lengthwise through the main body of the connector 5704a. The projections 5752 may additionally comprise one or more barbs 5754 attached thereto. Preferably, these barbs 5754 are angled proximally so as to act as anchors when pushed or inserted into the channel 5716. In some embodiments, the barbs 5754 may form an angle of 60° with the projection 5752. When the channel 5716 is a 3D fabric or knitted material, the barbs 5754 are configured to engage to the fibers therein, creating a more secure connection. At the proximal end of the connector 5704a, a lip 5756, which may be provided in a frustoconical form, may also be provided for connection to a tube 5740. The tube 5740 may be connected to the connector 5704a (as well as the other connectors described herein) for example by press-fitting, although other connections means are possible. The tube 5740 may be the same as tube 5507 in FIG. 2J, or it may be any other tube used to provide fluid communication with a source of negative pressure.


In FIGS. 4C-D, a connector 5704b has a proximal portion configured to fit around the exterior portion of a tube 5740, whereby the proximal portion is approximately cylindrical and has a cylindrical opening configured to receive the tube 5740, which can be secured by a press-fit. At about the center of the connector 5704b, a distally extending barb 5744 can be provided to attach to the channel 5716. Channels 5745 are preferably molded around the centrally-located barb 5744 and through the body of the connector 5704b so as to permit the flow of fluid through the connector 5704b and into the tube 5740.



FIG. 4E illustrates another embodiment of a connector 5704c, wherein the connector 5704c comprises a central, distally extending rod 5746 configured to be pushed into an inner region of the channel 5716. The connector 5704c is approximately cylindrical at its distal end, and tapers to form a smaller cylinder at its proximal end. It is at least partially hollowed out and has an inner channel configured to convey fluid from the material 5716 toward the tube 5740. At its proximal end, the connector 5704c comprises a lip 5765 similar to the lip 5742 described below in FIG. 4H, wherein the lip 5765 is configured to aid in maintaining a connection to a tube 5740 pushed onto the proximal end of the connector 5704c. In some configurations, the lip may 5765 may be made from rubber.



FIG. 4F illustrates an embodiment of a connector 5704d comprising a pin 5747 designed to secure the channel 5716 to the connector 5704d. Here, the connector 5704d may be pushed into the channel 5716. Alternatively, the channel 5716 may split partly lengthwise, so that an outer portion of the channel 5716 surrounds the connector 5704d when inserted therein. The pin 5747 is then inserted through the material of the channel 5716 and through apertures (not illustrated) in the connector 5704d. In some embodiments, the pin 5747 may have flared ends or other securement methods to prevent the pin 5747 from being displaced.



FIG. 4G illustrates a variation of the embodiment illustrated in FIG. 4F. Here, the connector 5704e may comprise a distally extending projection 5748 that extends over a portion of the channel 5716 and is configured to receive the pin 5747. In both of these embodiments, the connectors 5704d, 5704e may also be formed by creating a hole for the pin 5747 into a tube (and optionally by cutting away the tube as necessary), for example the tube 5740 illustrated previously, such that a separate connector piece is not necessary. Thus, a modified tube 5740 can replace the connector 5704d.


In FIG. 4H, the connector 5704f comprises distally extending hooked barbs 5741 that attach to upper and lower portions near the end of the channel 5716. The barbs 5741 are preferably made of an elastic or spring-like material that provides a force sufficient to sink and maintain the barbs 5741 into the material of the channel 5716. The body of the connector 5704f is preferably hollow so as to act as a fluid conduit. Of course, it may also be internally divided into multiple fluid channels extending through the body of the connector 5704f. At the other end of the connector 5704f, a lip 5742 may be provided to aid the connector 5704 in remaining connected to a tube 5740 so that fluids may be drained from the negative pressure treatment system.



FIG. 4I illustrates an embodiment of a cylindrical hollow connector 5704g similar to the embodiment illustrated in FIGS. 4A-B, this time provided with a distal, frustoconical tip 5744 molded around a central channel 5749 of the connector 5704g. As with other embodiments, a proximal frustoconical lip 5750 may be provided so as to provide a more secure connection to a tube 5740.



FIGS. 4J-L illustrates embodiments of a connector 5704h comprising a flexible line 5760 extending distally from a enlarged distal end or lip 5763 of the connector 5704h and forming a loop back to the enlarged distal end 5763. The line 5760 is configured to be received in a corresponding cavity 5762 formed on the enlarged distal end 5763 of the connector 5704h. In some embodiments, the line 5760 may have a tapered or barbed tip 5761 that is configured to securely lock into the cavity 5762. The line 5760 may also be provided with one or more barbs 5764. The body of the connector 5704h is preferably tubular so as to permit the flow of liquid from the wound. In use, the line 5760 may be pushed into the channel 5716 and looped around some or all of the material, followed by pushing the tip 5761 into the cavity 5762. The barbs 5764 may be useful in securing the connector 5704h to the channel 5716. When the channel 5716 is constructed from a 3D knitted or 3D fabric material, the line 5760 may be used to loop around and through the fibers that may extend through the middle part of the channel 5716, with the barbs 5764 helping to engage these fibers. Once secured to the channel 5716, the connector 5704h may be connected to a tube or other connector 5740.



FIGS. 5A-I all illustrate an embodiment of a connector 5800 similar to the connector 5704a illustrated in FIGS. 4A-B. In the embodiment illustrated, the connector 5800 comprises a main cylindrical body 5804, a proximal lip 5856 and distal projections 5852. A central channel 5855 extends lengthwise through the proximal lip 5856 and through the main cylindrical body. As illustrated in FIG. 5H, the central channel may have a substantially constant inner lumen at least through the proximal lip 5856 and the main cylindrical body 5804.


The distal projections 5852 may include two or more projections 5852 extending distally lengthwise from the preferably cylindrical main body 5804 of the connector 5800. These projections 5852 may additionally comprise one or more barbs 5854 attached thereto. For example, two barbs 5854 are shown on each of the projections in FIGS. 5A-I. The barbs 5854 may have sharp tips, or the tips may have rounded or blunt ends as illustrated in FIG. 5H. Preferably, these barbs 5854 are angled proximally (for example at an angle of 60° relative to the projections 5852) so as to act as anchors when pushed or inserted into the channel 5816 of a suction adapter (shown in FIG. 5I). The channel 5816 may be the same as channel 5716 of FIG. 4I or the same as channels 5512 and 5516 in FIGS. 2-3. When the channel 5816 is a 3D fabric or knitted material, the barbs 5854 are configured to engage to the fibers therein, creating a more secure connection.


The proximal portion of the projections 5852 may also comprise a reinforcing portion 5858 connecting the projections 5852 to the main body 5804, and which may be configured to provide additional strength. As illustrated in FIGS. 5B, 5C, 5G and 5H, the reinforcing portion 5858 may provide the projections 5852 with increased thickness at a proximal end of the projections 5852. This reinforcing portion 5858 may also provide additional resistance to minimize the likelihood of the projections 5852 becoming bent or twisted, for example when being inserted into the channel 5816. As illustrated in FIG. 5H, in one embodiment the distance between opposite projections 5852 may be larger than the diameter of the central channel 5855. The reinforcing portion 5858 in this embodiment serves as a transition along the inner surface of the projections 5852 to taper the opposing distance of the projections 5852 to the diameter of the central channel 5855.


In some embodiments, the distal end of the cylindrical body 5804 along its outer surface may be provided with an enlarged shoulder 5859, which is preferably rounded when viewed in profile in FIGS. 5B-E. Viewed from the bottom (as shown in FIG. 5G), part of the shoulder 5859 may be flattened to reduce its width along certain axes. If so provided, this shoulder 5859 may aid in securing the connector 5800 together with the barbs 5854 to the channel 5816. The outer diameter of the shoulder 5859 is preferably smaller than the distance between opposing barbs 5854.


At the proximal end of the connector 5800, a lip 5856, which may be provided in a frustoconical form, may also be used for connection to a tube 5840. In some embodiments, the lip 5856 may have a rounded proximal edge that may facilitate connecting to the tube 5840. As illustrated, in one embodiment the lip 5856 increases in outer dimension from its proximal end toward its distal end. At the distal end of the lip 5856, there is a step-down in outer dimension to the main cylindrical body 5804. The tube 5840 may be connected to the connector 5800 (as well as the other connectors described herein) for example by press-fitting, although other connections means are possible.


With reference to FIG. 5H, the central channel 5855 is preferably of a constant internal diameter between the proximal end of the connector 5804 and the distal end of the shoulder 5859 before the projections 5852. In some embodiments, the internal diameter of the central channel may range between 0.07-0.25 inches, for example 0.12 inches. The distance between the inner surfaces of opposing projections 5852 may typically be larger, preferably between 0.1-0.2 inches, for example 0.126 inches. The outer diameter of the main cylindrical portion 5804 of the connector 5800 preferably ranges between 0.1-0.55 inches, for example 0.19 inches. The lip 5856, as described previously, is preferably larger in diameter, and may measure between 0.2-0.3 inches, for example 0.25 inches, at its distal end or base. In some embodiments, the length of the entire connector 5800 including the projections 5852 may measure between 0.5-1 inch, for example 0.77 inches. The main body of the connector 5804, including the proximal lip 5856 and the shoulder 5859, may measure in length between 0.25 and 0.75 inches, for example 0.52 inches. The lip 5856 may measure in length between 0.1 and 0.3 inches, for example 0.2 inches. The shoulder 5859 may measure in length between 0.05 and 0.15 inches, for example 0.08 inches. The projections 5852 may measure in length between 0.15-0.3 inches, for example 0.25 inches, while the barbs 5854 may measure in length between 0.05-0.08 inches, for example 0.068 inches.


Although preferred dimensions have been provided for one embodiment of a connector 5800, it will be appreciated that connectors for use in negative pressure with other dimensions are also contemplated. This includes connectors having a length (including projections) of between 0.5 to 3 inches (between or about 0.5 to about 3 inches) and an inner diameter (of the central channel 5855) of between 0.05 to 1 inch. Suitable materials for the connector 5800 may include polymers, for example but without limitation polymers such as polypropylene, polyethylene, polystyrene, and blends thereof.


With reference again to FIG. 5I, the pulling force necessary to dislodge the connector 5800 (or any of the other connectors described herein) from the channel 5816 may be configured based on a number of factors. For example, the type and configuration of material used in the channel 5816 may be particularly selected, using materials and configurations such as described above. In addition, several features in the connector 5800 may be configured to determine how easily the connector 5800 is dislodged from the channel 5816. For example, the length and number of projections 5852, as well as the length and number of the barbs 5854 may be particularly configured. Further, the force necessary to buckle, yield or snap off the barbs 5854 also affects the pulling force necessary to dislodge the connector 5800. Additional factors, such as materials selection, post-processing of materials, adhesives, or other characteristics of the connector 5800, the channel 5816, and/or other aspects of the negative pressure treatment system may thus be tailored to modify the pulling force necessary to disconnect the connector 5800 from the channel 5816. In some embodiments, the pulling force sufficient to dislodge the connector 5800 from the channel 5816 may be tailored to fall within a range, for example, of between 1 kg to 100 kg, preferably between 10 kg to 50 kg, more preferably 20 kg or more as described above.


In some embodiments, the pulling force required to dislodge or disconnect any of the connectors described above may be optimized to provide a safety feature. For example, should an embodiment of the negative pressure treatment system 5502 become entangled or trapped while applied to a patient, the pulling force can be tailored so that a connector such as connector 5800 disconnects from the channel 5516 under such force. When the connector 5800 disconnects from the channel 5516, a separation may form between the connector and the channel layer. The layers 5514 and 5518 from the embodiment illustrated in FIG. 2D may then come together due to the negative pressure being applied to form a partial or complete seal. The resulting partial or complete blockage may be detected by a sensor and an alarm activated to alert the user to a problem with the system. In some embodiments, application of negative pressure may also be stopped upon detection of the blockage. In other embodiments the disconnection of the connector 5800 may also be sensed directly by a sensor placed adjacent the connector 5800, which may then set off an alarm. Accordingly, patient safety may be enhanced by reducing the likelihood of the system 5502 entangling a portion of a patient (e.g., a patient limb, causing a tourniquet effect) or strangling the patient.


The preceding embodiments illustrated in FIGS. 4A-L and 5A-I all share elements that make them suitable for incorporation into a flexible suction adapter system of the type described previously, and in particular for securement to a channel material such as a 3D fabric. Elements of the embodiments of connectors featuring barbs (such as FIGS. 4A-D, H, J-L; 5A-I) could be combined with other embodiments of connectors featuring pins (such as FIGS. 4F-G) to form an even more secure connection to a channel material. It will also be appreciated that the features of these connectors, particularly at the distal ends, can be incorporated onto the ends of tubes used to communicate negative pressure, such that those tubes can be directly connected to the suction adapter system.


While the above detailed description has shown, described, and pointed out novel features as applied to various embodiments, it will be understood that various omissions, substitutions, and changes in the form and details of the device or process illustrated may be made without departing from the spirit of the disclosure. Additionally, the various features and processes described above may be used independently of one another, or may be combined in various ways. All possible combinations and subcombinations are intended to fall within the scope of this disclosure. Many of the embodiments described above include similar components, and as such, these similar components can be interchanged in different embodiments.


Although the invention has been disclosed in the context of certain embodiments and examples, it will be understood by those skilled in the art that the invention extends beyond the specifically disclosed embodiments to other alternative embodiments and/or uses and obvious modifications and equivalents thereof. Accordingly, the invention is not intended to be limited by the specific disclosures of preferred embodiments herein.

Claims
  • 1. A negative pressure wound treatment system comprising: a wound dressing;an elongate bridge comprising: a fluid channel comprising a fabric material; andan enlarged distal end configured to be attached to the wound dressing; anda connector configured to connect to a conduit which is configured to deliver negative pressure to the wound from a source of negative pressure, the connector comprising: a proximal end configured to be coupled to the conduit; anda distal end coupled to the fluid channel comprising the fabric material;wherein the distal end of the connector extends into and beyond a proximal end of the fabric material and is adhered within the fabric material such that the fabric material surrounds a portion of the connector, andwherein the distal end of the connector comprises one or more projections extending distally from the connector, each projection configured to adhere to the fabric material, and each projection including at least one at least partially laterally extending barb.
  • 2. The system of claim 1, wherein the connector further comprises a lip at the proximal end of the connector, the lip configured to be press fit with the conduit.
  • 3. The system of claim 2, wherein the lip has a frustoconical shape.
  • 4. The system of claim 1, wherein the connector further comprises a hollow cylindrical body extending between the proximal end and the distal end of the connector and a central channel extending through the hollow cylindrical body.
  • 5. The system of claim 1, wherein the wound dressing comprises a cover layer configured to be positioned over a wound and sealed to skin surrounding the wound.
  • 6. The system of claim 1, wherein the elongate bridge is configured to attach to the wound dressing and surround at least one aperture formed in the wound dressing.
  • 7. The system of claim 1, wherein the fabric material comprises knitted fibers.
  • 8. The system of claim 1, wherein the fabric material comprises nylon.
  • 9. The system of claim 1, wherein the connector is configured to withstand a pulling force of up to 20 kg before disengaging from the fabric material.
  • 10. A negative pressure wound treatment system comprising: a wound dressing comprising a cover layer configured to be positioned over a wound and sealed to skin surrounding the wound; anda suction adapter comprising: a top layer constructed from a liquid impermeable material;a bottom layer constructed from a liquid impermeable material;a spacer layer located between the top and bottom layers, the spacer layer comprising a fabric material;an elongate channel extending between the top and bottom layers containing the spacer layer, wherein the top layer and the bottom layer include enlarged distal ends with the channel extending in a proximal direction away from the enlarged ends;wherein the suction adapter is configured to attach to the cover layer and surround at least one aperture formed in the cover layer; anda connector configured to connect to a conduit which is configured deliver negative pressure to the wound from a source of negative pressure, the connector comprising: a proximal end configured to be coupled to the conduit; anda distal end coupled to the elongate channel containing the spacer layer; andwherein the distal end of the connector extends into and beyond a proximal end of the spacer layer and is adhered within the fabric material of the spacer layer such that the fabric material surrounds a portion of the connector andwherein the distal end of the connector comprises one or more projections extending distally from the connector, each projection configured to be pushed into and be retained within the fabric material of the elongate channel, and each projection including at least one at least partially laterally extending barb.
  • 11. The system of claim 10, wherein the connector further comprises a frustoconical lip at the proximal end of the connector, the lip configured to be press fit with the tube.
  • 12. The system of claim 10, wherein the connector further comprises a hollow cylindrical body extending between the proximal end and the distal end of the connector and a central channel extending through the hollow cylindrical body.
  • 13. The system of claim 10, wherein the fabric material comprises knitted fibers.
  • 14. The system of claim 10, wherein the fabric material comprises nylon.
  • 15. The system of claim 10, wherein the connector is configured to withstand a pulling force of up to 20 kg before disengaging from the fabric material.
  • 16. The system of claim 1, wherein a portion of the connector hooks onto fibers of the fabric material.
  • 17. The system of claim 10, wherein a portion of the connector hooks onto fibers of the fabric material.
CROSS REFERENCE TO RELATED APPLICATIONS

This application is a continuation of U.S. application Ser. No. 14/730,040, filed Jun. 3, 2015, which is a continuation of U.S. application Ser. No. 13/381,884, filed Jul. 12, 2013, which is a U.S. National Phase of the PCT International Application No. PCT/US2011/041521 filed on Jun. 22, 2011, designating the United States, which claims priority to U.S. Provisional Application Ser. No. 61/426,432, filed Dec. 22, 2010. The disclosure of each of these prior applications is incorporated by reference in its entirety and should be considered a part of this specification.

US Referenced Citations (406)
Number Name Date Kind
1585104 Montgomery May 1926 A
2736317 Alexander Feb 1956 A
3042041 Jascalevich Jul 1962 A
3255749 Smithers Jun 1966 A
3568675 Harvey Mar 1971 A
3572340 Lloyd et al. Mar 1971 A
3874387 Barbieri Apr 1975 A
3880164 Stepno Apr 1975 A
3927443 Brumlik Dec 1975 A
3943734 Fleissner Mar 1976 A
4080970 Miller Mar 1978 A
4117551 Brooks et al. Sep 1978 A
4164027 Bonnie et al. Aug 1979 A
4169303 Lemelson Oct 1979 A
4231357 Hessner Nov 1980 A
4261363 Russo Apr 1981 A
4360015 Mayer Nov 1982 A
4382441 Svedman May 1983 A
4392853 Muto Jul 1983 A
4468219 George et al. Aug 1984 A
4538920 Drake Sep 1985 A
4540412 Van Overloop Sep 1985 A
4553967 Ferguson et al. Nov 1985 A
4561435 McKnight et al. Dec 1985 A
4569674 Phillips Feb 1986 A
4579120 MacGregor Apr 1986 A
4605399 Weston et al. Aug 1986 A
4614183 McCracken et al. Sep 1986 A
4665909 Trainor May 1987 A
4753536 Spehar et al. Jun 1988 A
4767026 Keller et al. Aug 1988 A
4771919 Ernst Sep 1988 A
4872450 Austad Oct 1989 A
4906240 Reed et al. Mar 1990 A
4921492 Schultz May 1990 A
4941882 Ward et al. Jul 1990 A
4969880 Zamierowski Nov 1990 A
4980226 Hellgren et al. Dec 1990 A
5009224 Cole Apr 1991 A
5056510 Gilman Oct 1991 A
5060642 Gilman Oct 1991 A
5064653 Sessions et al. Nov 1991 A
5080493 McKown et al. Jan 1992 A
5088483 Heinecke Feb 1992 A
5100396 Zamierowski Mar 1992 A
5106362 Gilman Apr 1992 A
5112323 Winkler et al. May 1992 A
5134007 Reising et al. Jul 1992 A
5139023 Stanley et al. Aug 1992 A
5147698 Cole Sep 1992 A
5149331 Ferdman et al. Sep 1992 A
5152757 Eriksson Oct 1992 A
5160315 Heinecke et al. Nov 1992 A
5160334 Billings et al. Nov 1992 A
5176663 Svedman et al. Jan 1993 A
5180375 Feibus Jan 1993 A
5218973 Weaver Jun 1993 A
5230496 Shillington et al. Jul 1993 A
5244457 Karami et al. Sep 1993 A
5249709 Duckworth et al. Oct 1993 A
5261893 Zamierowski Nov 1993 A
5263922 Sova et al. Nov 1993 A
5300054 Feist et al. Apr 1994 A
5304161 Noel et al. Apr 1994 A
5308313 Karami et al. May 1994 A
5333760 Simmen Aug 1994 A
5358492 Feibus Oct 1994 A
5366451 Levesque Nov 1994 A
5391161 Hellgren et al. Feb 1995 A
5437651 Todd et al. Aug 1995 A
5439458 Noel et al. Aug 1995 A
5447492 Cartmell et al. Sep 1995 A
5486167 Dragoo et al. Jan 1996 A
5520629 Heinecke et al. May 1996 A
5525407 Yang Jun 1996 A
5527293 Zamierowski Jun 1996 A
5527923 Klingler et al. Jun 1996 A
5531855 Heinecke et al. Jul 1996 A
5549584 Gross Aug 1996 A
5582596 Fukunaga et al. Dec 1996 A
5593750 Rothrum et al. Jan 1997 A
5599289 Castellana Feb 1997 A
5603145 Arakawa Feb 1997 A
5609271 Keller et al. Mar 1997 A
5613942 Lucast et al. Mar 1997 A
5618278 Rothrum Apr 1997 A
5618556 Johns et al. Apr 1997 A
5624423 Anjur et al. Apr 1997 A
5636643 Argenta et al. Jun 1997 A
5637093 Hyman et al. Jun 1997 A
5645081 Argenta et al. Jul 1997 A
5678564 Lawrence et al. Oct 1997 A
5695846 Lange et al. Dec 1997 A
5701917 Khouri Dec 1997 A
5738642 Heinecke et al. Apr 1998 A
5738656 Wagner Apr 1998 A
5795584 Totakura et al. Aug 1998 A
5797844 Yoshioka et al. Aug 1998 A
5797894 Cadieux et al. Aug 1998 A
5885237 Kadash et al. Mar 1999 A
5894608 Birbara Apr 1999 A
5910150 Saadat Jun 1999 A
5911222 Lawrence et al. Jun 1999 A
5914282 Dunshee et al. Jun 1999 A
5928265 Fleischmann Jul 1999 A
5964723 Augustine Oct 1999 A
6071267 Zamierowski Jun 2000 A
6117111 Fleischmann Sep 2000 A
6121508 Bischof et al. Sep 2000 A
6142982 Hunt et al. Nov 2000 A
6149614 Dunshee et al. Nov 2000 A
6169224 Heinecke et al. Jan 2001 B1
6252129 Coffee Jun 2001 B1
6264976 Heinecke et al. Jul 2001 B1
6291050 Cree et al. Sep 2001 B1
6345623 Heaton et al. Feb 2002 B1
6391294 Dettmar et al. May 2002 B1
6398761 Bills et al. Jun 2002 B1
6406447 Thrash et al. Jun 2002 B1
6420622 Johnston et al. Jul 2002 B1
6436432 Heinecke et al. Aug 2002 B2
6458109 Henley et al. Oct 2002 B1
6461467 Blatchford et al. Oct 2002 B2
6471685 Johnson Oct 2002 B1
6479073 Lucast et al. Nov 2002 B1
6486285 Fujita Nov 2002 B2
6553998 Heaton et al. Apr 2003 B2
6566575 Stickels et al. May 2003 B1
6607799 Heinecke et al. Aug 2003 B1
6626891 Ohmstede Sep 2003 B2
6629774 Gruendeman Oct 2003 B1
6648862 Watson Nov 2003 B2
6685681 Lockwood et al. Feb 2004 B2
6685682 Heinecke et al. Feb 2004 B1
6752794 Lockwood et al. Jun 2004 B2
6755807 Risk et al. Jun 2004 B2
6800074 Henley et al. Oct 2004 B2
6814079 Heaton et al. Nov 2004 B2
6824533 Risk, Jr. et al. Nov 2004 B2
6838589 Liedtke et al. Jan 2005 B2
6855135 Lockwood et al. Feb 2005 B2
6867342 Johnston et al. Mar 2005 B2
6878857 Chihani et al. Apr 2005 B1
6903243 Burton Jun 2005 B1
6936037 Bubb et al. Aug 2005 B2
6951553 Bubb et al. Oct 2005 B2
D515701 Horhota et al. Feb 2006 S
6994702 Johnson Feb 2006 B1
6994904 Joseph et al. Feb 2006 B2
7004915 Boynton et al. Feb 2006 B2
7005143 Abuelyaman et al. Feb 2006 B2
7048818 Krantz May 2006 B2
7070580 Nielsen Jul 2006 B2
7070584 Johnson et al. Jul 2006 B2
7108683 Zamierowski Sep 2006 B2
7117869 Heaton et al. Oct 2006 B2
7128735 Weston Oct 2006 B2
7183454 Rosenberg Feb 2007 B1
7195624 Lockwood Mar 2007 B2
7198046 Argenta et al. Apr 2007 B1
7216651 Argenta et al. May 2007 B2
7273054 Heaton et al. Sep 2007 B2
7276247 Fansler et al. Oct 2007 B2
7279612 Heaton et al. Oct 2007 B1
7285576 Hyde et al. Oct 2007 B2
7316672 Hunt et al. Jan 2008 B1
7338482 Lockwood et al. Mar 2008 B2
7381859 Hunt et al. Jun 2008 B2
7438705 Karpowicz et al. Oct 2008 B2
7442849 Heinecke Oct 2008 B2
7485112 Karpowicz et al. Feb 2009 B2
7503910 Adahan Mar 2009 B2
7531711 Sigurjonsson et al. May 2009 B2
7534927 Lockwood May 2009 B2
7569742 Haggstrom et al. Aug 2009 B2
7585554 Johnson et al. Sep 2009 B2
7586019 Oelund et al. Sep 2009 B2
7615036 Joshi et al. Nov 2009 B2
7625362 Boehringer et al. Dec 2009 B2
7645269 Zamierowski Jan 2010 B2
7651484 Heaton et al. Jan 2010 B2
7670323 Hunt et al. Mar 2010 B2
7678102 Heaton Mar 2010 B1
7686785 Boehringer et al. Mar 2010 B2
7699831 Bengtson et al. Apr 2010 B2
7717313 Criscuolo et al. May 2010 B2
7723560 Lockwood May 2010 B2
7745681 Ferguson Jun 2010 B1
7754937 Boehringer et al. Jul 2010 B2
7758554 Lina et al. Jul 2010 B2
7759537 Bishop et al. Jul 2010 B2
7759539 Shaw et al. Jul 2010 B2
7776028 Miller et al. Aug 2010 B2
7779625 Joshi et al. Aug 2010 B2
7781639 Johnston et al. Aug 2010 B2
7790945 Watson, Jr. Sep 2010 B1
7790946 Mulligan Sep 2010 B2
7794438 Henley et al. Sep 2010 B2
7794450 Blott Sep 2010 B2
7803980 Griffiths et al. Sep 2010 B2
7815616 Boehringer et al. Oct 2010 B2
7846141 Weston Dec 2010 B2
7857806 Karpowicz et al. Dec 2010 B2
7862718 Doyen et al. Jan 2011 B2
7880050 Robinson Feb 2011 B2
7896823 Mangrum et al. Mar 2011 B2
7896856 Petrosenko et al. Mar 2011 B2
7896864 Lockwood et al. Mar 2011 B2
7922703 Riesinger Apr 2011 B2
7942866 Radl May 2011 B2
7951124 Boehringer et al. May 2011 B2
7976533 Larsson Jul 2011 B2
7981098 Boehringer et al. Jul 2011 B2
8002313 Singh et al. Aug 2011 B2
8007257 Heaton et al. Aug 2011 B2
8008538 Ugander et al. Aug 2011 B2
8021347 Vitaris et al. Sep 2011 B2
8057449 Sanders et al. Nov 2011 B2
8061360 Locke et al. Nov 2011 B2
8083712 Biggie et al. Dec 2011 B2
8097272 Addison Jan 2012 B2
8100887 Weston et al. Jan 2012 B2
8114126 Heaton Feb 2012 B2
8133211 Cavanaugh, II et al. Mar 2012 B2
8142419 Heaton Mar 2012 B2
8147468 Barta et al. Apr 2012 B2
8148595 Robinson et al. Apr 2012 B2
8148596 Miau et al. Apr 2012 B2
8152785 Vitaris Apr 2012 B2
8158844 McNeil Apr 2012 B2
8162907 Heagle Apr 2012 B2
8168848 Lockwood et al. May 2012 B2
8177764 Hu et al. May 2012 B2
8188331 Barta et al. May 2012 B2
8192409 Hardman Jun 2012 B2
8197467 Heaton Jun 2012 B2
8202261 Kazala, Jr. et al. Jun 2012 B2
8235939 Johnson et al. Aug 2012 B2
8241261 Randolph et al. Aug 2012 B2
8298200 Vess et al. Oct 2012 B2
8372049 Jaeb et al. Feb 2013 B2
8382731 Johannison Feb 2013 B2
D679819 Peron Apr 2013 S
D679820 Peron Apr 2013 S
8409170 Locke et al. Apr 2013 B2
8439893 Wakabayashi May 2013 B2
8608776 Coward Dec 2013 B2
8623047 Cornet Jan 2014 B2
8690845 Long et al. Apr 2014 B2
8708998 Weston et al. Apr 2014 B2
8721629 Hardman May 2014 B2
8734410 Hall et al. May 2014 B2
8771244 Eckstein et al. Jul 2014 B2
8784392 Vess et al. Jul 2014 B2
8801685 Armstrong Aug 2014 B2
8814842 Coulthard et al. Aug 2014 B2
D714433 Armstrong et al. Sep 2014 S
8843327 Vernon-Harcourt et al. Sep 2014 B2
8870837 Locke et al. Oct 2014 B2
8905985 Allen et al. Dec 2014 B2
8951235 Allen et al. Feb 2015 B2
9017302 Vitaris et al. Apr 2015 B2
9050398 Armstrong Jun 2015 B2
9061095 Adie et al. Jun 2015 B2
D746435 Armstrong et al. Dec 2015 S
RE45864 Peron Jan 2016 E
9227000 Fink et al. Jan 2016 B2
9327065 Albert May 2016 B2
9474654 Heagle et al. Oct 2016 B2
RE46289 Peron Jan 2017 E
9539373 Jones et al. Jan 2017 B2
9642750 Albert May 2017 B2
9681993 Wu et al. Jun 2017 B2
D804014 Armstrong et al. Nov 2017 S
RE46825 Heagle May 2018 E
9956389 Armstrong May 2018 B2
9974695 Albert May 2018 B2
9999547 Albert Jun 2018 B2
10065030 Kantrowitz et al. Sep 2018 B2
10406037 Albert Sep 2019 B2
RE48117 Albert Jul 2020 E
10744239 Armstrong Aug 2020 B2
20010034223 Rieser et al. Oct 2001 A1
20020002209 Mork Jan 2002 A1
20020182246 Oyaski Dec 2002 A1
20030050594 Zamierowski Mar 2003 A1
20030171675 Rosenberg Sep 2003 A1
20030225347 Argenta et al. Dec 2003 A1
20040039415 Zamierowski Feb 2004 A1
20040054338 Bybordi Mar 2004 A1
20040064132 Boehringer et al. Apr 2004 A1
20050004534 Lockwood Jan 2005 A1
20050020955 Sanders et al. Jan 2005 A1
20050065484 Watson, Jr. Mar 2005 A1
20050085795 Lockwood Apr 2005 A1
20050101940 Radl et al. May 2005 A1
20050137539 Biggie et al. Jun 2005 A1
20050273066 Wittmann Dec 2005 A1
20060009744 Edrman et al. Jan 2006 A1
20060036221 Watson, Jr. Feb 2006 A1
20060079852 Bubb et al. Apr 2006 A1
20060100586 Karpowicz May 2006 A1
20070038172 Zamierowski Feb 2007 A1
20070129707 Blott Jun 2007 A1
20070156104 Lockwood et al. Jul 2007 A1
20070167927 Hunt et al. Jul 2007 A1
20070219497 Johnson et al. Sep 2007 A1
20070219512 Heaton Sep 2007 A1
20070233022 Henley et al. Oct 2007 A1
20070260226 Jaeb Nov 2007 A1
20080033325 Van der Hulst et al. Feb 2008 A1
20080103489 Dahners May 2008 A1
20080161778 Steward Jul 2008 A1
20080167593 Fleischmann Jul 2008 A1
20080195017 Robinson Aug 2008 A1
20080200906 Sanders et al. Aug 2008 A1
20080208147 Argenta et al. Aug 2008 A1
20080243096 Svedman Oct 2008 A1
20080275409 Kane et al. Nov 2008 A1
20080281281 Meyer et al. Nov 2008 A1
20080287892 Khan et al. Nov 2008 A1
20080294147 Radi et al. Nov 2008 A1
20080300578 Freedman Dec 2008 A1
20080306456 Riesinger Dec 2008 A1
20090005744 Karpowicz et al. Jan 2009 A1
20090012501 Boehringer et al. Jan 2009 A1
20090043268 Eddy Feb 2009 A1
20090093778 Svedman Apr 2009 A1
20090099519 Kaplan Apr 2009 A1
20090124988 Coulthard May 2009 A1
20090131892 Karpowicz et al. May 2009 A1
20090137973 Karpowicz et al. May 2009 A1
20090157016 Adahan Jun 2009 A1
20090171288 Wheeler Jul 2009 A1
20090204085 Biggie Aug 2009 A1
20090227968 Vess Sep 2009 A1
20090264837 Adahan Oct 2009 A1
20090264838 Livne Oct 2009 A1
20090281526 Kenny et al. Nov 2009 A1
20090287133 LaGreca, Sr. Nov 2009 A1
20090293887 Wilkes et al. Dec 2009 A1
20090299249 Wilkes et al. Dec 2009 A1
20090299251 Buan Dec 2009 A1
20090299255 Kazala, Jr. et al. Dec 2009 A1
20090299257 Long et al. Dec 2009 A1
20090299303 Seegert Dec 2009 A1
20090299308 Kazala et al. Dec 2009 A1
20090299340 Kazala et al. Dec 2009 A1
20090312723 Blott Dec 2009 A1
20100000524 Ohbi Jan 2010 A1
20100036334 Heagle Feb 2010 A1
20100069850 Fabo Mar 2010 A1
20100069858 Olson Mar 2010 A1
20100069863 Olson Mar 2010 A1
20100069885 Stevenson et al. Mar 2010 A1
20100087767 McNeil Apr 2010 A1
20100094234 Ramella et al. Apr 2010 A1
20100106106 Heaton Apr 2010 A1
20100106114 Weston Apr 2010 A1
20100106121 Holm Apr 2010 A1
20100125258 Coulthard et al. May 2010 A1
20100152639 Miau et al. Jun 2010 A1
20100160878 Hunt et al. Jun 2010 A1
20100160901 Hu et al. Jun 2010 A1
20100174250 Hu Jul 2010 A1
20100185163 Heagle Jul 2010 A1
20100191197 Braga Jul 2010 A1
20100191198 Heagle Jul 2010 A1
20100210986 Sanders Aug 2010 A1
20100262091 Larsson Oct 2010 A1
20100268128 Randolph Oct 2010 A1
20100305524 Vess Dec 2010 A1
20100324510 Andresen et al. Dec 2010 A1
20100324516 Braga Dec 2010 A1
20110028919 Johnnison et al. Feb 2011 A1
20110125066 Robinson et al. May 2011 A1
20110125110 Cotton May 2011 A1
20110130712 Topaz Jun 2011 A1
20110172582 Darian Jul 2011 A1
20110230849 Coulthard Sep 2011 A1
20110245682 Robinson et al. Oct 2011 A1
20120116334 Albert May 2012 A1
20120143156 Bannister et al. Jun 2012 A1
20120302976 Locke et al. Nov 2012 A1
20130066284 Croizat Mar 2013 A1
20130066286 Croizat Mar 2013 A1
20130066365 Belson Mar 2013 A1
20130144230 Wu Jun 2013 A1
20130172835 Braga et al. Jul 2013 A1
20130204213 Heagle Aug 2013 A1
20130253453 Olson Sep 2013 A1
20130310809 Armstrong Nov 2013 A1
20140330224 Albert Nov 2014 A1
20140343520 Bennett et al. Nov 2014 A1
20150073358 Jaeb et al. Mar 2015 A1
20150343194 Armstrong Dec 2015 A1
20160151548 Albert Jun 2016 A1
20160375184 Albert Dec 2016 A1
20170035617 Albert Feb 2017 A1
20170216501 Armstrong Aug 2017 A1
20180028365 Albert Feb 2018 A1
20180304065 Armstrong Oct 2018 A1
20180308578 Armstrong Oct 2018 A1
20190380881 Albert Dec 2019 A1
20200100945 Albert Apr 2020 A1
20200289723 Gregory Sep 2020 A1
Foreign Referenced Citations (230)
Number Date Country
674837 Jan 1997 AU
3 907 007 Sep 1990 DE
20 2010 009 148 Oct 2010 DE
0 325 771 Sep 1993 EP
0 392 640 Jun 1995 EP
0 441 418 Jul 1995 EP
0 465 601 Jan 1997 EP
0 751 757 Jan 1997 EP
0 692 987 Oct 1997 EP
0 853 950 Jul 1998 EP
0 651 983 Sep 1998 EP
0 777 504 Oct 1998 EP
0 782 421 Jul 1999 EP
1 018 967 Jul 2000 EP
0 690 706 Nov 2000 EP
1 129 734 Sep 2001 EP
0 921 775 Dec 2001 EP
1 169 071 Jan 2002 EP
0 708 620 May 2003 EP
1 014 905 May 2003 EP
1 088 569 Aug 2003 EP
0 993 317 Sep 2003 EP
0 880 953 Oct 2003 EP
1 219 311 Jul 2004 EP
1 440 667 Jul 2004 EP
1 448 261 Aug 2004 EP
1 100 574 Feb 2005 EP
0 688 189 Jun 2005 EP
1 284 777 Apr 2006 EP
0 982 015 Aug 2006 EP
0 620 720 Nov 2006 EP
1 227 853 Jan 2008 EP
1 476 217 Mar 2008 EP
1906903 Apr 2008 EP
1 920 791 May 2008 EP
1 233 808 Jul 2008 EP
1977776 Oct 2008 EP
1993491 Nov 2008 EP
1 827 561 Jan 2009 EP
2 052 750 Apr 2009 EP
2 098 257 Sep 2009 EP
2 103 290 Sep 2009 EP
2 127 690 Dec 2009 EP
2138139 Dec 2009 EP
1 652 549 Jan 2010 EP
1 905 465 Jan 2010 EP
2203137 Jul 2010 EP
2 218 431 Aug 2010 EP
2244217 Oct 2010 EP
2244746 Nov 2010 EP
1 703 922 May 2011 EP
2 319 550 May 2011 EP
2 349 155 Aug 2011 EP
1 578 477 Sep 2011 EP
1 763 378 Dec 2011 EP
2 529 766 Dec 2012 EP
2 659 915 Nov 2013 EP
2 628 500 May 2014 EP
2307180 May 1997 GB
2336546 Oct 1999 GB
2344531 Jul 2000 GB
2356148 May 2001 GB
2431351 Apr 2007 GB
H04-503625 Jul 1992 JP
H08-098706 Apr 1996 JP
2001314479 Nov 2001 JP
WO 199403214 Feb 1994 WO
WO 199421207 Sep 1994 WO
WO 199423678 Oct 1994 WO
WO 199901173 Jan 1999 WO
WO 2000007653 Feb 2000 WO
WO 200061206 Oct 2000 WO
WO 2000064394 Nov 2000 WO
WO 2001085228 Nov 2001 WO
WO 2001085248 Nov 2001 WO
WO 2002043634 Jun 2002 WO
WO 2002070040 Sep 2002 WO
WO-02092783 Nov 2002 WO
WO 2003086232 Oct 2003 WO
WO 2003101508 Dec 2003 WO
WO 2004018020 Mar 2004 WO
WO 2004037334 May 2004 WO
WO 2004041064 May 2004 WO
WO 2004060148 Jul 2004 WO
WO 2005009488 Feb 2005 WO
WO 2005016179 Feb 2005 WO
WO 2005025447 Mar 2005 WO
WO 2005046760 May 2005 WO
WO 2005046761 May 2005 WO
WO 2005046762 May 2005 WO
WO 2005051461 Jun 2005 WO
WO 2005061025 Jul 2005 WO
WO 2005072789 Aug 2005 WO
WO 2005079718 Sep 2005 WO
WO 2005102415 Nov 2005 WO
WO 2005105174 Nov 2005 WO
WO 2005105175 Nov 2005 WO
WO 2005105176 Nov 2005 WO
WO 2005105179 Nov 2005 WO
WO 2005105180 Nov 2005 WO
WO 2005107842 Nov 2005 WO
WO 2005115497 Dec 2005 WO
WO 2005115523 Dec 2005 WO
WO 2005123170 Dec 2005 WO
WO 2006046060 May 2006 WO
WO 2006052338 May 2006 WO
WO 2006052745 May 2006 WO
WO 2006114637 Nov 2006 WO
WO 2006114638 Nov 2006 WO
WO 2006114648 Nov 2006 WO
WO 2007006306 Jan 2007 WO
WO 2007013049 Feb 2007 WO
WO 2007013064 Feb 2007 WO
WO 2007015964 Feb 2007 WO
WO 2007016590 Feb 2007 WO
WO 2007019038 Feb 2007 WO
WO 2007030598 Mar 2007 WO
WO 2007030599 Mar 2007 WO
WO 2007030601 Mar 2007 WO
WO 2007031757 Mar 2007 WO
WO 2007031762 Mar 2007 WO
WO 2007031765 Mar 2007 WO
WO 2007041642 Apr 2007 WO
WO 2007062024 May 2007 WO
WO 2007067685 Jun 2007 WO
WO-2007084792 Jul 2007 WO
WO 2007085396 Aug 2007 WO
WO 2007087808 Aug 2007 WO
WO 2007087809 Aug 2007 WO
WO 2007087811 Aug 2007 WO
WO 2007092397 Aug 2007 WO
WO 2007095180 Aug 2007 WO
WO 2007106590 Sep 2007 WO
WO 2007106591 Sep 2007 WO
WO 2007133618 Nov 2007 WO
WO 2007143060 Dec 2007 WO
WO 2008008032 Jan 2008 WO
WO 2008010094 Jan 2008 WO
WO 2008011774 Jan 2008 WO
WO 2008012278 Jan 2008 WO
WO 2008013896 Jan 2008 WO
WO 2008014358 Jan 2008 WO
WO 2008016304 Feb 2008 WO
WO 2008027449 Mar 2008 WO
WO 2008036162 Mar 2008 WO
WO 2008040020 Apr 2008 WO
WO 2008041926 Apr 2008 WO
WO 2008043067 Apr 2008 WO
WO 2008048527 Apr 2008 WO
WO 2008064502 Jun 2008 WO
WO 2008086397 Jul 2008 WO
WO 2008100437 Aug 2008 WO
WO 2008100440 Aug 2008 WO
WO 2008100446 Aug 2008 WO
WO 2008112304 Sep 2008 WO
WO 2008131895 Nov 2008 WO
WO 2008132215 Nov 2008 WO
WO 2008135997 Nov 2008 WO
WO 2008141470 Nov 2008 WO
WO 2008154158 Dec 2008 WO
WO 2009002260 Dec 2008 WO
WO 2009004370 Jan 2009 WO
WO 2009016603 Feb 2009 WO
WO 2009016605 Feb 2009 WO
WO 2009019229 Feb 2009 WO
WO 2009021047 Feb 2009 WO
WO 2009021353 Feb 2009 WO
WO 2009034322 Mar 2009 WO
WO 2009062327 May 2009 WO
WO 2009066104 May 2009 WO
WO 2009066106 May 2009 WO
WO 2009067711 May 2009 WO
WO 2009068665 Jun 2009 WO
WO 2009071926 Jun 2009 WO
WO 2009071929 Jun 2009 WO
WO 2009071932 Jun 2009 WO
WO 2009071933 Jun 2009 WO
WO 2009071935 Jun 2009 WO
WO 2009071948 Jun 2009 WO
WO 2009078790 Jun 2009 WO
WO 2009086580 Jul 2009 WO
WO 2009088925 Jul 2009 WO
WO 2009111655 Sep 2009 WO
WO 2009114624 Sep 2009 WO
WO 2009114760 Sep 2009 WO
WO 2009114790 Sep 2009 WO
WO 2009124473 Oct 2009 WO
WO 2009124548 Oct 2009 WO
WO 2009126102 Oct 2009 WO
WO 2009126103 Oct 2009 WO
WO 2009137194 Nov 2009 WO
WO 2009140376 Nov 2009 WO
WO 2009145703 Dec 2009 WO
WO 2009145894 Dec 2009 WO
WO 2009158125 Dec 2009 WO
WO 2009158126 Dec 2009 WO
WO 2009158127 Dec 2009 WO
WO 2009158129 Dec 2009 WO
WO-2009146441 Dec 2009 WO
WO 2010014177 Feb 2010 WO
WO 2010033271 Mar 2010 WO
WO 2010033272 Mar 2010 WO
WO 2010033769 Mar 2010 WO
WO 2010035017 Apr 2010 WO
WO 2010042240 Apr 2010 WO
WO 2010051071 May 2010 WO
WO 2010056977 May 2010 WO
WO 2010059712 May 2010 WO
WO 2010072395 Jul 2010 WO
WO 2010078166 Jul 2010 WO
WO 2010094957 Aug 2010 WO
WO 2010120470 Oct 2010 WO
WO 2010147533 Dec 2010 WO
WO 2011049562 Apr 2011 WO
WO 2011087871 Jul 2011 WO
WO-2011091052 Jul 2011 WO
WO 2011100851 Aug 2011 WO
WO-2011091952 Aug 2011 WO
WO 2011115908 Sep 2011 WO
WO 2012028842 Mar 2012 WO
WO 2012142002 Oct 2012 WO
WO 2012174672 Dec 2012 WO
WO 2013013938 Jan 2013 WO
WO 2013016239 Jan 2013 WO
WO 2013019438 Feb 2013 WO
WO 2013043972 Mar 2013 WO
WO 2013123005 Aug 2013 WO
WO 2014066057 May 2014 WO
WO 2014043238 Sep 2014 WO
WO 2014158526 Oct 2014 WO
Non-Patent Literature Citations (12)
Entry
US 7,186,244 B1, 03/2007, Hunt et al. (withdrawn)
Fleischmann, W. et al., “Vacuum Sealing: Indication, Technique, and Results”, Eur J Orthop Surg Traumatol, vol. 5, 1995, pp. 37-40, in 5 pages.
Greer, S. et al., “Techniques for Applying Subatmospheric Pressure Dressing to Wounds in Difficult Regions of Anatomy”, JWOCN, vol. 26(5), 1999, pp. 250-253, in 4 pages.
International Report on Patentability, re PCT Application No. PCT/US2011/041521, dated Jun. 25, 2013.
International Search Report and Written Opinion, re PCT Application No. PCT/US2011/041521, dated Oct. 7, 2011.
Jeter, K. et al., “Managing Draining Wounds and Fistulae: New and Established Methods”, Chronic Wound Care, 1990, pp. 240-246, in 7 pages.
KCI V.A.C. Granufoam Bridge Dressing Product Brochure (2009), in 2 pages.
Bevan D., et al., “Diverse and potent activities of HGF/SF in skin wound repair,” Journal of Pathology, vol. 203, 2004, pp. 831-838.
Info V.A.C. User Manual, KCI on Dec. 1, 2006 in 76 pages.
Landis E.M., et al., “The Effects of Alternate Suction and Pressure on Blood Flow to the Lower Extremities,” Alternate Suction and Pressure, J Clin Invest, Sep. 1993, vol. 12 (5), pp. 925-961.
Mitchell R.N., et al., “Role of Stem Cells in Tissue Homeostasis,” Pocket Companion to Robbins and Cotran Pathologic Basis of Disease, 7th Edition, 2006, p. 55 (3 pages).
Morykwas M.J., et al., “Nonsurgical Modalities to Enhance Healing and Care of Soft Tissue Wounds,” Journal of the Southern Orthopaedic Association, vol. 6, No. 4, 1997, pp. 279-288.
Related Publications (1)
Number Date Country
20180304065 A1 Oct 2018 US
Provisional Applications (1)
Number Date Country
61426432 Dec 2010 US
Continuations (2)
Number Date Country
Parent 14730040 Jun 2015 US
Child 15952070 US
Parent 13381884 US
Child 14730040 US